# BYSL

## Overview
The BYSL gene encodes the bystin-like protein, which is integral to ribosomal biogenesis and cell adhesion processes. Bystin-like is primarily categorized as a nucleolar protein due to its significant role in the synthesis and maturation of the 40S ribosomal subunit, particularly in the processing of 18S rRNA, which is essential for protein synthesis and cell proliferation (Miyoshi2007Bystin; Fukuda2007The). Additionally, bystin-like is involved in the nuclear export of the 40S subunit and is regulated by the mTOR signaling pathway, highlighting its importance in cellular stress responses (Miyoshi2007Bystin). Beyond its role in ribosome biogenesis, bystin-like is implicated in cell adhesion during embryo implantation, interacting with proteins such as trophinin and tastin to facilitate blastocyst attachment to the uterine wall (Fukuda2007The). This dual functionality underscores the protein's critical involvement in both cellular and developmental processes.

## Function
The BYSL gene encodes the protein bystin, which is crucial for ribosomal biogenesis in human cells. Bystin is primarily located in the nucleolus, where it plays a significant role in the synthesis and processing of the 40S ribosomal subunit, particularly in the maturation of 18S rRNA (Miyoshi2007Bystin; Fukuda2007The). This process is essential for protein synthesis and cell proliferation, as the 40S subunit is a key component of the ribosome, which translates mRNA into proteins (Miyoshi2007Bystin; Adachi2007Crucial).

Bystin is also involved in the nuclear export of the 40S subunit, associating with it in the cytoplasm before translation initiation (Miyoshi2007Bystin). Its expression is regulated by the mTOR signaling pathway, which is crucial for ribosome biogenesis and cellular response to stress (Miyoshi2007Bystin). In addition to its role in ribosome biogenesis, bystin is implicated in cell adhesion processes, particularly during embryo implantation, where it interacts with trophinin and tastin to facilitate the initial adhesion of the blastocyst to the uterus (Fukuda2007The). This dual role in ribosome biogenesis and cell adhesion underscores bystin's importance in both cellular and organismal contexts.

## Clinical Significance
The BYSL gene has significant clinical implications in various cancers due to its altered expression and genetic mutations. High expression of BYSL is associated with poor prognosis in several cancers, including adrenocortical carcinoma, breast cancer, and glioblastoma, where it promotes cell migration, invasion, and epithelial-mesenchymal transition (EMT) through pathways like GSK-3β/β-catenin (Sha2020BYSL; Li2022BYSL:). In hepatocellular carcinoma (HCC), BYSL is crucial for nucleologenesis and cell proliferation, with its knockdown leading to reduced tumor growth, suggesting its potential as a therapeutic target (Wang2009Bystinlike).

In osteosarcoma, BYSL overexpression is linked to metastasis and poor survival, enhancing Nrf2 signaling and promoting EMT under hypoxic conditions. The miR-378a-3p/BYSL axis is significant in regulating these processes, with miR-378a-3p inhibiting BYSL expression and reducing EMT (Zhang2022HypoxiaInduced). Genetic alterations, such as amplifications and missense mutations, are common in various tumors, although they do not significantly affect survival in some cancers (Li2022BYSL:). Overall, BYSL's role in cancer progression and its potential as a biomarker make it a focus for diagnostic and therapeutic strategies.

## Interactions
The BYSL protein, also known as bystin-like, is involved in several critical interactions with other proteins and nucleic acids, playing a significant role in nucleologenesis and ribosomal biogenesis. BYSL interacts with nucleolar proteins such as Ubf, fibrillarin, nucleolin, and B23, which are essential for nucleolar assembly. The knockdown of BYSL disrupts the localization and function of these proteins, leading to impaired nucleologenesis and cell growth (Wang2009Bystinlike). BYSL also forms complexes with trophinin and tastin, proteins involved in cell adhesion and spindle assembly, respectively (Wang2009Bystinlike).

In the context of ribosomal biogenesis, BYSL is involved in the processing of 18S rRNA, a component of the 40S ribosomal subunit, indicating its interaction with nucleic acids during ribosome assembly (Fukuda2007The). It is associated with the cytoplasmic 40S subunit before translation initiation and is crucial for 18S rRNA processing (Fukuda2007The). These interactions highlight BYSL's multifaceted role in cell division and cancer progression, making it a potential target for cancer therapy (Wang2009Bystinlike).


## References


1. (Li2022BYSL:) BYSL: A Novel Biomarker for Cancer Treatment. This article has 0 citations.

[2. (Fukuda2007The) M. N. Fukuda, M. Miyoshi, and D. Nadano. The role of bystin in embryo implantation and in ribosomal biogenesis. Cellular and Molecular Life Sciences, 65(1):92–99, October 2007. URL: http://dx.doi.org/10.1007/s00018-007-7302-9, doi:10.1007/s00018-007-7302-9. This article has 20 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-007-7302-9)

[3. (Wang2009Bystinlike) Hanzhi Wang, Wei Xiao, Qinbo Zhou, Yun Chen, Shuo Yang, Jiansong Sheng, Yanqing Yin, Jia Fan, and Jiawei Zhou. Bystin-like protein is upregulated in hepatocellular carcinoma and required for nucleologenesis in cancer cell proliferation. Cell Research, 19(10):1150–1164, August 2009. URL: http://dx.doi.org/10.1038/cr.2009.99, doi:10.1038/cr.2009.99. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/cr.2009.99)

[4. (Adachi2007Crucial) Kenjiro Adachi, Chie Soeta-Saneyoshi, Hiroshi Sagara, and Yoichiro Iwakura. Crucial role of bysl in mammalian preimplantation development as an integral factor for 40s ribosome biogenesis. Molecular and Cellular Biology, 27(6):2202–2214, March 2007. URL: http://dx.doi.org/10.1128/MCB.01908-06, doi:10.1128/mcb.01908-06. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.01908-06)

[5. (Sha2020BYSL) Zhuang Sha, Junbo Zhou, Yihao Wu, Tong Zhang, Cheng Li, Qingming Meng, Preethi Priyanka Musunuru, Fangting You, Yue Wu, Rutong Yu, and Shangfeng Gao. Bysl promotes glioblastoma cell migration, invasion, and mesenchymal transition through the gsk-3β/β-catenin signaling pathway. Frontiers in Oncology, October 2020. URL: http://dx.doi.org/10.3389/fonc.2020.565225, doi:10.3389/fonc.2020.565225. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2020.565225)

[6. (Miyoshi2007Bystin) Masaya Miyoshi, Tetsuya Okajima, Tsukasa Matsuda, Michiko N. Fukuda, and Daita Nadano. Bystin in human cancer cells: intracellular localization and function in ribosome biogenesis. Biochemical Journal, 404(3):373–381, May 2007. URL: http://dx.doi.org/10.1042/bj20061597, doi:10.1042/bj20061597. This article has 35 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20061597)

[7. (Zhang2022HypoxiaInduced) Junlei Zhang, Haijun Tang, Xiaohong Jiang, Nenggan Huang, and Qingjun Wei. Hypoxia-induced mir-378a-3p inhibits osteosarcoma invasion and epithelial-to-mesenchymal transition via bysl regulation. Frontiers in Genetics, January 2022. URL: http://dx.doi.org/10.3389/fgene.2021.804952, doi:10.3389/fgene.2021.804952. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2021.804952)